Texas Instruments stock holds with $160 target at TD Cowen

Published 04/24/2025, 10:21 AM
© Reuters.

On Thursday, TD Cowen maintained a Hold rating on Texas Instruments (NASDAQ:TXN) stock with a steady price target of $160.00, falling within the broader analyst range of $125 to $250. The firm’s analyst, Joshua Buchalter, acknowledged the company’s strong performance and guidance improvement despite concerns about the second half of the year’s visibility and ongoing tariff issues. According to InvestingPro data, the stock currently trades at an EV/EBITDA multiple of 22.5x.

Texas Instruments recently reported financial results that exceeded expectations and provided an optimistic outlook, with the company noting a significant reduction in customer inventory levels. All business segments showed quarter-over-quarter growth, except for the seasonally weaker Personal Electronics (PE) sector. The company maintains strong financial health with a current ratio of 4.12x and has impressively raised its dividend for 21 consecutive years, demonstrating consistent shareholder returns.

Buchalter mentioned the challenge of having confidence in the visibility for the second half of 2025, citing the unpredictable nature of customer order pull-ins as a potential issue that could affect investor sentiment towards Texas Instruments and its industry peers. In light of these uncertainties, the analyst has adjusted the company’s earnings estimates for the second half of 2025 and the full year of 2026. For deeper insights into TXN’s valuation and growth prospects, investors can access comprehensive analysis through InvestingPro, which offers 12 additional exclusive tips about the company.

The analyst’s commentary highlighted the improving fundamentals within the company, but also pointed out the concerns that prevent a more optimistic stance. The valuation and uncertain market conditions were cited as reasons for maintaining the Hold rating and the $160 price target for Texas Instruments stock. Based on InvestingPro’s Fair Value analysis, the stock appears to be trading near its fair value, with a gross profit margin of 58.14% supporting its premium market position.

In other recent news, Texas Instruments has reported strong financial results for the first quarter of 2025, with earnings per share (EPS) of $1.28, surpassing the forecast of $1.06, and revenue reaching $4.1 billion, exceeding expectations of $3.91 billion. The company has provided positive guidance for the second quarter, projecting revenue between $4.17 billion and $4.53 billion. Despite the robust performance, several analysts have adjusted their price targets for Texas Instruments. Cantor Fitzgerald reduced its target to $170, while maintaining a Neutral rating, due to the uncertain macroeconomic climate. Truist Securities also lowered its target to $171, citing minimal tariff impact but maintaining a Hold rating. KeyBanc Capital Markets set a new target of $215 with an Overweight rating, acknowledging the company’s strong quarterly performance and recovery in the industrial sector. JPMorgan decreased its target to $195, maintaining an Overweight rating but expressing caution about potential tariff impacts in the latter half of the year. These adjustments reflect broader economic factors and industry trends, as Texas Instruments continues to navigate geopolitical uncertainties and tariff-related challenges.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.